Cargando…
A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction
Background: Prostate cancer (PCa) is one of the most common cancers in males around the globe, and about one-third of patients with localized PCa will experience biochemical recurrence (BCR) after radical prostatectomy or radiation therapy. Reportedly, a proportion of patients with BCR had a poor pr...
Autores principales: | Zheng, Pengxiang, Long, Zining, Gao, Anding, Lu, Jianming, Wang, Shuo, Zhong, Chuanfan, Lai, Houhua, Guo, Yufei, Wang, Ke, Fang, Chen, Mao, Xiangming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871836/ https://www.ncbi.nlm.nih.gov/pubmed/36704346 http://dx.doi.org/10.3389/fgene.2022.1110799 |
Ejemplares similares
-
5-Methylcytosine RNA Methyltransferases-Related Long Non-coding RNA to Develop and Validate Biochemical Recurrence Signature in Prostate Cancer
por: Wang, Ke, et al.
Publicado: (2021) -
Gut dysbiosis promotes prostate cancer progression and docetaxel resistance via activating NF-κB-IL6-STAT3 axis
por: Zhong, Weibo, et al.
Publicado: (2022) -
An Immune Gene-Related Five-lncRNA Signature for to Predict Glioma Prognosis
por: Wang, Xinzhuang, et al.
Publicado: (2020) -
Construction of five cuproptosis-related lncRNA signature for predicting prognosis and immune activity in skin cutaneous melanoma
por: Yang, Xiaojing, et al.
Publicado: (2022) -
A prognostic pyroptosis-related LncRNA classifier associated with the immune landscape and therapy efficacy in glioma
por: Zhong, Jiasheng, et al.
Publicado: (2022)